The Medical Advisor

OneDayMD | Practical Wellness & Evidence Review Updated: October 13, 2026 · Reading time: about 10–12 minutes A small herb garden can make everyday cooking fresher, attract pollinators, and give you a convenient supply of aromatic plants traditionally used in home care. But a plant's long history of use—or activity seen in a laboratory—does not automatically mean it treats an illness in people. This guide reviews 10 herbs commonly recommended for a home apothecary: sage, thyme, rosemary, oregano, lemon balm, chamomile, fennel, lavender, calendula, and garlic. It explains the most practical uses, what the research can and cannot tell us, how to grow each plant, and the main safety issues to consider before using herbs medicinally. Important: Think of these plants as a kitchen and gardening resource—not a substitute for diagnosis, prescribed treatment, or urgent care. Evidence and safety depend on the species, plant part, preparation, dose, and person ...

Medically Reviewed by: Dr. Frank Yap, MD | Written by: OneDayMD Editorial Team | Published: March 2026 | Last updated: October 6, 2026 Quick Answer As of October 2026, tirzepatide (Zepbound) is the strongest FDA-approved option at about 20–21% average weight loss, ahead of semaglutide (Wegovy) at about 15% (20.7% at the new 7.2 mg dose). Retatrutide, a triple agonist, reached 28.3% at 80 weeks in Phase 3 but is not FDA-approved ; Lilly plans to file in Q1 2027. What changed in this update (Oct 2026): replaced pre-Phase-3 estimates with TRIUMPH-1/2/3 results; corrected retatrutide launch timing (not before late 2027); added Wegovy HD, the Wegovy pill, Foundayo and CagriSema context; removed claims sourced only from research-peptide vendors, forum posts and unverified preprints; added CEBM evidence tiers, FAQ and an AI-prompt guide. Contents At-a-glance comparison How the three work What the trials show (and don't) Retatrutide: status in October 2026 Muscle and lean...

Medically Reviewed by: Dr Frank Yap, MD | Compiled  by:   OneDayMD Editorial Team | Last Updated:  September  2026 Contents: Introduction Lymphoma Case Series (31 case reports) Leukemia Case Series (15 case reports) Discussion Conclusion Important Disclaimers:  This content is for educational purposes only and does not constitute medical advice. Ivermectin is used off-label for cancer treatment. Always consult with a knowledgeable physician whom you trust to manage your health. Individual results may vary. Do not self-medicate with ivermectin without proper bloodwork and medical monitoring, as misuse can lead to serious side effects and drug interactions. Ivermectin and mebendazole are used off-label as complementary therapies and are not intended to replace conventional, evidence-based cancer treatments such as chemotherapy, radiotherapy, immunotherapy, targeted therapy, or hormone therapy. Any off-label use should be discussed with and supervised by a qua...